These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17130306)

  • 1. Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension.
    Morecroft I; Dempsie Y; Bader M; Walther DJ; Kotnik K; Loughlin L; Nilsen M; MacLean MR
    Hypertension; 2007 Jan; 49(1):232-6. PubMed ID: 17130306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice.
    Izikki M; Hanoun N; Marcos E; Savale L; Barlier-Mur AM; Saurini F; Eddahibi S; Hamon M; Adnot S
    Am J Physiol Lung Cell Mol Physiol; 2007 Oct; 293(4):L1045-52. PubMed ID: 17675372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.
    Dempsie Y; Morecroft I; Welsh DJ; MacRitchie NA; Herold N; Loughlin L; Nilsen M; Peacock AJ; Harmar A; Bader M; MacLean MR
    Circulation; 2008 Jun; 117(22):2928-37. PubMed ID: 18506000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension.
    MacLean MR; Deuchar GA; Hicks MN; Morecroft I; Shen S; Sheward J; Colston J; Loughlin L; Nilsen M; Dempsie Y; Harmar A
    Circulation; 2004 May; 109(17):2150-5. PubMed ID: 15078799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3.
    Steudel W; Scherrer-Crosbie M; Bloch KD; Weimann J; Huang PL; Jones RC; Picard MH; Zapol WM
    J Clin Invest; 1998 Jun; 101(11):2468-77. PubMed ID: 9616218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.
    Naito Y; Hosokawa M; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Eguchi A; Nishimura K; Soyama Y; Hirotani S; Mano T; Ishihara M; Masuyama T
    Heart Vessels; 2016 Dec; 31(12):2074-2079. PubMed ID: 27311944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of pulmonary vascular remodeling and right ventricular pressure in tissue angiotensin-converting enzyme-deficient mice under conditions of chronic alveolar hypoxia.
    van Suylen RJ; Aartsen WM; Smits JF; Daemen MJ
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1241-5. PubMed ID: 11316665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935.
    Keegan A; Morecroft I; Smillie D; Hicks MN; MacLean MR
    Circ Res; 2001 Dec; 89(12):1231-9. PubMed ID: 11739290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.
    Levi M; Moons L; Bouché A; Shapiro SD; Collen D; Carmeliet P
    Circulation; 2001 Apr; 103(15):2014-20. PubMed ID: 11306532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt5a attenuates hypoxia-induced pulmonary arteriolar remodeling and right ventricular hypertrophy in mice.
    Jin Y; Wang W; Chai S; Liu J; Yang T; Wang J
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1742-51. PubMed ID: 25956683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial ET(B) limits vascular remodelling and development of pulmonary hypertension during hypoxia.
    Kelland NF; Bagnall AJ; Morecroft I; Gulliver-Sloan FH; Dempsie Y; Nilsen M; Yanagisawa M; Maclean MR; Kotelevtsev YV; Webb DJ
    J Vasc Res; 2010; 47(1):16-22. PubMed ID: 19672104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.
    Ciuclan L; Hussey MJ; Burton V; Good R; Duggan N; Beach S; Jones P; Fox R; Clay I; Bonneau O; Konstantinova I; Pearce A; Rowlands DJ; Jarai G; Westwick J; MacLean MR; Thomas M
    Am J Respir Crit Care Med; 2013 Jan; 187(1):78-89. PubMed ID: 23087024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice.
    Satoh K; Kagaya Y; Nakano M; Ito Y; Ohta J; Tada H; Karibe A; Minegishi N; Suzuki N; Yamamoto M; Ono M; Watanabe J; Shirato K; Ishii N; Sugamura K; Shimokawa H
    Circulation; 2006 Mar; 113(11):1442-50. PubMed ID: 16534010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension.
    Ochoa CD; Yu L; Al-Ansari E; Hales CA; Quinn DA
    J Cardiothorac Surg; 2010 May; 5():32. PubMed ID: 20441584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin-deficient neonatal mice are not protected against the development of experimental bronchopulmonary dysplasia or pulmonary hypertension.
    Roberts DS; Sherlock LG; Posey JN; Archambault JL; Nozik ES; Delaney CA
    Physiol Rep; 2022 Oct; 10(19):e15482. PubMed ID: 36200294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) in chronic hypoxia- and antigen-mediated pulmonary vascular remodeling.
    Angelini DJ; Su Q; Yamaji-Kegan K; Fan C; Skinner JT; Poloczek A; El-Haddad H; Cheadle C; Johns RA
    Respir Res; 2013 Jan; 14(1):1. PubMed ID: 23289668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia.
    Weissmann N; Manz D; Buchspies D; Keller S; Mehling T; Voswinckel R; Quanz K; Ghofrani HA; Schermuly RT; Fink L; Seeger W; Gassmann M; Grimminger F
    Thromb Haemost; 2005 Sep; 94(3):630-8. PubMed ID: 16268482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.
    Chen YF; Feng JA; Li P; Xing D; Zhang Y; Serra R; Ambalavanan N; Majid-Hassan E; Oparil S
    J Appl Physiol (1985); 2006 Feb; 100(2):564-71. PubMed ID: 16223981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension after prolonged hypoxic exposure in mice with a congenital deficiency of Cyp2j.
    Beloiartsev A; da Glória Rodrigues-Machado M; Zhou GL; Tan TC; Zazzeron L; Tainsh RE; Leyton P; Jones RC; Scherrer-Crosbie M; Zapol WM
    Am J Respir Cell Mol Biol; 2015 May; 52(5):563-70. PubMed ID: 25233285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.